Michael R. Mc Mullen Agilent Technologies, Inc. (A) insider trading activity

Michael R. Mc Mullen is CEO and President of AGILENT TECHNOLOGIES, INC.. Currently has a direct ownership of 253,908 shares of A, which is worth approximately $34 Million. The most recent transaction as insider was on Mar 08, 2024, when has been sold 52,297 shares (Common Stock) at a price of $150.0 per share, resulting in proceeds of $7,844,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 254K

0% 3M change

17.08% 12M change

Total Value Held $34 Million

Michael R. McMullen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2024	SELL Open market or private sale	$7,844,550 $150.0 p/Share	52,297 Reduced 17.08%	253,908 Common Stock
Dec 13 2023	SELL Open market or private sale	$357,630 $130.0 p/Share	2,751 Reduced 0.89%	306,205 Common Stock
Dec 13 2023	BUY Exercise of conversion of derivative security	$115,872 $42.12 p/Share	2,751 Added 0.88%	308,956 Common Stock
Dec 07 2023	SELL Open market or private sale	$8,120,710 $130.0 p/Share	62,467 Reduced 16.94%	306,205 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$2,631,110 $42.12 p/Share	62,467 Added 14.49%	368,672 Common Stock
Nov 22 2023	BUY Grant, award, or other acquisition	$3,123,928 $123.99 p/Share	25,195 Added 7.6%	306,205 Common Stock
Nov 17 2023	SELL Payment of exercise price or tax liability	$1,154,808 $113.15 p/Share	10,206 Reduced 3.5%	281,010 Common Stock
Nov 16 2023	SELL Payment of exercise price or tax liability	$229,864 $114.19 p/Share	2,013 Reduced 0.69%	291,216 Common Stock
Nov 15 2023	SELL Payment of exercise price or tax liability	$285,136 $113.6 p/Share	2,510 Reduced 0.85%	293,229 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$3,557,791 $111.61 p/Share	31,877 Reduced 9.73%	295,739 Common Stock
Nov 14 2023	BUY Grant, award, or other acquisition	$7,449,744 $111.61 p/Share	66,748 Added 16.93%	327,616 Common Stock
Jul 27 2023	SELL Open market or private sale	$122,720 $130.0 p/Share	944 Reduced 0.36%	260,868 Common Stock
Jul 27 2023	BUY Exercise of conversion of derivative security	$39,761 $42.12 p/Share	944 Added 0.36%	261,812 Common Stock
Nov 22 2022	SELL Open market or private sale	$20,046,499 $155.73 p/Share	128,726 Reduced 33.06%	260,691 Common Stock
Nov 22 2022	BUY Exercise of conversion of derivative security	$5,252,020 $40.8 p/Share	128,726 Added 24.84%	389,417 Common Stock
Nov 18 2022	SELL Payment of exercise price or tax liability	$1,095,255 $146.19 p/Share	7,492 Reduced 2.79%	260,691 Common Stock
Nov 17 2022	SELL Payment of exercise price or tax liability	$391,865 $144.44 p/Share	2,713 Reduced 1.0%	268,183 Common Stock
Nov 16 2022	SELL Open market or private sale	$1,003,987 $148.19 p/Share	6,775 Reduced 2.44%	270,896 Common Stock
Nov 16 2022	SELL Payment of exercise price or tax liability	$296,152 $147.12 p/Share	2,013 Reduced 0.74%	270,896 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$276,420 $40.8 p/Share	6,775 Added 2.38%	277,671 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$10,092,860 $148.0 p/Share	68,195 Reduced 19.99%	272,909 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	$23,352,772 $148.0 p/Share	157,789 Added 31.63%	341,104 Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$1,192,857 $148.31 p/Share	8,043 Reduced 4.2%	183,315 Common Stock
Nov 09 2022	SELL Open market or private sale	$937,050 $138.31 p/Share	6,775 Reduced 3.42%	191,358 Common Stock
Nov 09 2022	BUY Exercise of conversion of derivative security	$276,420 $40.8 p/Share	6,775 Added 3.31%	198,133 Common Stock

Also insider at

KLAC

KLA CORP Technology

BMY

BRISTOL MYERS SQUIBB CO Healthcare

Director

MRM